DaSilva JO, Yang K, Surriga O, Nittoli T, et al. A Biparatopic Antibody-Drug Conjugate to Treat MET-Expressing Cancers, Including Those that Are Unresponsive to MET Pathway Blockade. Mol Cancer Ther 2021;20:1966-1976.
PMID: 34315762